This code was added to ICD-10-CM to capture the rapidly growing use of these agents and distinguish them from both oral agents (Z79.84) and insulin (Z79.4)
Bcl-2, Bcl-XL may confer resistance to Fas/Fas ligand mediated apoptosis in chronic lymphocytic leukemia (CLL) cells
Weight loss improves mobility and energy for exercise
Compounded medications are not FDA-approved as finished products and have not undergone the same evaluation process
Other names include Captin, Disprol, Dymadon, Fensum, Hedex, Mexalen, Nofedol, Paralen, Pediapirin, Perfalgan, and Solpadeine
A consultation may review medication questions, appetite return, nutrition, protein, activity, metabolic testing, 3D body scanning, and behavioral maintenance